Sarilumab (IL-6R inhibitor) in phase 3 trial for relapsing PMR (SAPHYR trial). Key inclusion: Disease flare while taking >7.5mg prednisolone Sustained remission: resolution of symptoms, normalisation of CRP, adherence to prednisolone taper @RheumNow #ACR22 #Plenary